Abstract:Aims: To compare how OCT4A proteins interact with and regulate multiple OCT4A-octamer motifs (OMs) in different regions of the FOS gene expressed in somatic cancer cells versus pluripotent stem cells. Materials and methods: Two FOS reporter gene systems harboring predicted OMs or their mutational counterparts were introduced into HeLa and NCCIT cells with varying OCT4A protein levels. The transcription of dsGFP reflecting FOS expression was quantitated by RT-qPCR, the OCT4A-OMs binding and the correlation between OCT4A and FOS transcription was determined by ChIP-PCR and RNA-Seq, respectively. Key findings: In NCCIT cells, abundant OCT4A proteins bound to and inhibited OM1 and OM2 at the promoter of the FOS gene. RA-induced OCT4A down-regulation transiently increased FOS transcription. In contrast, in HeLa cells that contain much lower levels of endogenous OCT4A proteins, OCT4A primarily bound to and activate OM1 thereby promoting FOS transcription. OCT4A KO significantly reduced FOS expression. Ectopically introduced OCT4A, at its leaked or induced expression level, promoted FOS transcription by binding to OM2/OM3 or OM1/OM3, respectively. Thus, the interaction of OCT4A proteins with different OMs is cellular context- and protein level-dependent, and such complicated OCT4A binding mode can only be reflected by a dsGFP-based reporter harboring the full-length FOS gene but not by that merely having the FOS promoter. Significance: Our findings unravel an additional layer of regulatory mechanisms that account for the cellular context- and dose-related versatile functions of OCT4A protein, and further underscore the importance of precise modulation of OCT4A in the regenerative medicine and anticancer therapies.

Nspc1 Regulates the Key Pluripotent Oct4–Nanog–Sox2 Axis in P19 Embryonal Carcinoma Cells Via Directly Activating Oct4

NSPc1 is a cell growth regulator that acts as a transcriptional repressor of p21Waf1/Cip1 via the RARE element.

Translationally controlled tumor protein (TCTP) downregulates Oct4 expression in mouse pluripotent cells.

Whole genome binding sites of stem cell regulator nervous system polycomb 1

Nanog regulates molecules involved in stemness and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells

The OCT4-RNA Interactome in Pluripotent Stem Cells Reveals Direct Translational Regulation of the AKT-Pathway Genes by OCT4

Cellular Context- and Protein Level-Dependent Interaction of Pluripotency Factor OCT4A with Multiple Octamer Motifs of the Same Target Gene

Site-Specific Disruption of the Oct4/Sox2 Protein Interaction Reveals Coordinated Mesendodermal Differentiation and the Epithelial-Mesenchymal Transition

Foxa1 contributes to the repression of Nanog expression by recruiting Grg3 during the differentiation of pluripotent P19 embryonal carcinoma cells.

Foxm1 Transcription Factor is Required for Maintenance of Pluripotency of P19 Embryonal Carcinoma Cells

Pcbp1 constrains Oct4 expression in the context of pluripotency

NSPc1, a Mainly Nuclear Localized Protein of Novel PcG Family Members, Has a Transcription Repression Activity Related to Its PKC Phosphorylation Site at S183

NAC1 Regulates Somatic Cell Reprogramming by Controlling Zeb1 and E-cadherin Expression.

p18 inhibits reprogramming through inactivation of Cdk4/6

PHC1 maintains pluripotency by organizing genome-wide chromatin interactions of the Nanog locus

Transcriptional Regulation of Nanog by OCT4 and SOX2

PCGF6 controls neuroectoderm specification of human pluripotent stem cells by activating SOX2 expression

Oct4 regulates the miR-302 cluster in P19 mouse embryonic carcinoma cells

Stable Expression of FoxA1 Promotes Pluripotent P19 Embryonal Carcinoma Cells to Be Neural Stem-Like Cells.

Increased levels of FoxA1 transcription factor in pluripotent P19 embryonal carcinoma cells stimulate neural differentiation.

The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells